ロード中...

A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer

The immunohistochemical determination of HER-2 to identify patients with advanced breast cancer candidates for Trastuzumab treatment proved neither accurate nor fully reliable, possibly because none of the current reagents detects the specific antigenic site target of Trastuzumab. To circumvent this...

詳細記述

保存先:
書誌詳細
主要な著者: Bussolati, G, Montemurro, F, Righi, L, Donadio, M, Aglietta, M, Sapino, A
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2005
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361978/
https://ncbi.nlm.nih.gov/pubmed/15812476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602507
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!